Purdue Research Foundation Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza March 7, 2025 Read
Purdue Research Foundation Purdue Innovates funds advances in ag biotechnology, cancer treatments and fiber optics March 6, 2025 Read
Purdue Research Foundation Purdue printing innovation fabricates multilevel microfluidic devices as small as 10 microns deep March 5, 2025 Read
Purdue Research Foundation High-tech startup CrySyst provides quality-by-control solutions for pharmaceutical, fine chemical industries February 25, 2025 Read
Purdue Research Foundation Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk February 18, 2025 Read
Purdue Research Foundation Emboa Medical creates, validates novel catheter to improve stroke patients’ outcomes February 17, 2025 Read
Purdue Research Foundation New Purdue compounds could make conventional personal care products sustainable February 11, 2025 Read
Purdue Research Foundation Purdue SAFE-RWSL surveillance system built to prevent airport runway incursions December 16, 2024 Read
Purdue Research Foundation Purdue, IU researchers to use $1.5 million grant to test patent-pending autonomic dysreflexia monitoring device December 10, 2024 Read
Purdue Research Foundation Purdue Research Foundation names Greg Deason as chief operating officer December 6, 2024 Read
Purdue Research Foundation Cement grows stronger, more resilient with Purdue cellulose innovation December 3, 2024 Read
Purdue Research Foundation Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies November 19, 2024 Read